SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001737287-22-000085
Filing Date
2022-11-02
Accepted
2022-11-02 16:43:39
Documents
11
Effectiveness Date
2022-11-02

Document Format Files

Seq Description Document Type Size
1 S-3ASR allo-20221102xformsx3asr.htm S-3ASR 493918
2 EX-FILING FEES allo-20221102xex107.htm EX-FILING FEES 54936
3 EX-1.2 allo-20221102xex12.htm EX-1.2 287312
4 EX-4.7 allo-20221102xex47.htm EX-4.7 470408
5 EX-4.10 allo-20221102xex410.htm EX-4.10 144503
6 EX-4.11 allo-20221102xex411.htm EX-4.11 148830
7 EX-4.12 allo-20221102xex412.htm EX-4.12 128784
8 EX-5.1 allo-20221102xex51.htm EX-5.1 37697
9 EX-23.1 allo-20221102xex231.htm EX-23.1 2792
10 cooleya06.jpg GRAPHIC 10201
11 g725933allogenea08.jpg GRAPHIC 7772
  Complete submission text file 0001737287-22-000085.txt   1795185
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-268117 | Film No.: 221354797
SIC: 2836 Biological Products, (No Diagnostic Substances)